Market Overview:
The global medicinal cannabis market is expected to grow at a CAGR of 23.8% from 2018 to 2030. The growth in the market can be attributed to the increasing legalization of cannabis for medical purposes, rising awareness about the benefits of cannabis-based therapies, and growing demand for cannabinoid-based drugs. The global medicinal cannabis market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into oral medications and topical medications. Oral medications are further classified into capsules and tinctures/drops. Topical medications are further classified into balms, creams/lotions, patches, and oils/serums. On the basis of application, hospitals account for a major share in terms of revenue in 2017; however clinics are expected to witness higher growth during the forecast period owing to their increasing adoption for various treatments such as chronic pain management and cancer therapy).
Product Definition:
Medicinal cannabis is any form of the cannabis plant that is used to treat illness or improve symptoms. Cannabis has been used medicinally for thousands of years, and research suggests it may be effective in treating a wide variety of conditions.
Oral Medications:
Oral medications are drugs that are taken in the mouth. They can be administered as solid or liquid forms. The most common types of oral medications include anti-inflammatory drugs, analgesics (painkillers), vitamins, minerals and others.
Topical Medications:
Topical medications are those used to treat the skin, hair, and nails. Topical medicines can be used with other forms of treatment for medicinal purposes. Some common examples of topical medications include corticosteroids (such as betamethasone), coal tar, fluorouracil (such as Fluoroplex or Sunopta), hydroxy acids such as lactic acid and salicylic acid among others.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics, and medical research centers. Hospitals held the largest share of revenue in 2017 owing to presence of a large patient base that can be treated with vaporized or oral forms of cannabis and growing number of hospital-based clinical trials. However, due to strict regulations regarding medicinal cannabis use in hospitals across the world, its usage has been limited to date.
Medical research centers are expected to witness lucrative growth over the forecast period owing to increase in government funding for marijuana-related studies at universities and institutes as well as an increasing number of private companies focusing on development of novel products for medical uses.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to presence of large number of companies and increased R&D activities for development of new products. In addition, increasing cases of chronic pain and cancer are expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness fastest growth over the next eight years owing to increase in awareness about medicinal cannabis among patients, physicians, and other stakeholders coupled with growing acceptance by government agencies & regulatory bodies for use as a medicine.
In addition, economic development in Asian countries such as China.
Growth Factors:
- Increasing legalization of cannabis for medical purposes across the globe.
- Growing research on therapeutic benefits of cannabis for various diseases and disorders.
- Rising demand from patients suffering from chronic pain, cancer, arthritis, and other medical conditions.
- Availability of Medicinal Cannabis in different forms such as tinctures, oils, pills, and vaporizers etc., which is making it easier for patients to use them as per their convenience and preference . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Medicinal Cannabis Market Research Report
By Type
Oral Medications, Topical Medications
By Application
Hospitals, Clinics, Medical Research Centers
By Companies
GreenWich, Abbvie, Insys Therapeutics, Valeant Pharmaceuticals, Tilray, Corbus Pharmaceuticals, Aphria, Manitoba Harvest, Phytokann, Botanical Genetics, Jinzhou Qiaopai Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Medicinal Cannabis Market Report Segments:
The global Medicinal Cannabis market is segmented on the basis of:
Types
Oral Medications, Topical Medications
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Medical Research Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GreenWich
- Abbvie
- Insys Therapeutics
- Valeant Pharmaceuticals
- Tilray
- Corbus Pharmaceuticals
- Aphria
- Manitoba Harvest
- Phytokann
- Botanical Genetics
- Jinzhou Qiaopai Biotech
Highlights of The Medicinal Cannabis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Medications
- Topical Medications
- By Application:
- Hospitals
- Clinics
- Medical Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medicinal Cannabis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medicinal cannabis is a plant-based extract that has been used to treat a variety of medical conditions for centuries. Cannabis oil is made from the dried flowers and leaves of the cannabis plant.
Some of the major companies in the medicinal cannabis market are GreenWich, Abbvie, Insys Therapeutics, Valeant Pharmaceuticals, Tilray, Corbus Pharmaceuticals, Aphria, Manitoba Harvest, Phytokann, Botanical Genetics, Jinzhou Qiaopai Biotech.
The medicinal cannabis market is expected to grow at a compound annual growth rate of 23.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medicinal Cannabis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medicinal Cannabis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medicinal Cannabis Market - Supply Chain
4.5. Global Medicinal Cannabis Market Forecast
4.5.1. Medicinal Cannabis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medicinal Cannabis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medicinal Cannabis Market Absolute $ Opportunity
5. Global Medicinal Cannabis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medicinal Cannabis Market Size and Volume Forecast by Type
5.3.1. Oral Medications
5.3.2. Topical Medications
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medicinal Cannabis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medicinal Cannabis Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Medical Research Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medicinal Cannabis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medicinal Cannabis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medicinal Cannabis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medicinal Cannabis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medicinal Cannabis Demand Share Forecast, 2019-2026
9. North America Medicinal Cannabis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medicinal Cannabis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medicinal Cannabis Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Medical Research Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medicinal Cannabis Market Size and Volume Forecast by Type
9.7.1. Oral Medications
9.7.2. Topical Medications
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medicinal Cannabis Demand Share Forecast, 2019-2026
10. Latin America Medicinal Cannabis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medicinal Cannabis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medicinal Cannabis Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Medical Research Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medicinal Cannabis Market Size and Volume Forecast by Type
10.7.1. Oral Medications
10.7.2. Topical Medications
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medicinal Cannabis Demand Share Forecast, 2019-2026
11. Europe Medicinal Cannabis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medicinal Cannabis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medicinal Cannabis Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Medical Research Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medicinal Cannabis Market Size and Volume Forecast by Type
11.7.1. Oral Medications
11.7.2. Topical Medications
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medicinal Cannabis Demand Share, 2019-2026
12. Asia Pacific Medicinal Cannabis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medicinal Cannabis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medicinal Cannabis Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Medical Research Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medicinal Cannabis Market Size and Volume Forecast by Type
12.7.1. Oral Medications
12.7.2. Topical Medications
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medicinal Cannabis Demand Share, 2019-2026
13. Middle East & Africa Medicinal Cannabis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medicinal Cannabis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medicinal Cannabis Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Medical Research Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medicinal Cannabis Market Size and Volume Forecast by Type
13.7.1. Oral Medications
13.7.2. Topical Medications
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medicinal Cannabis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medicinal Cannabis Market: Market Share Analysis
14.2. Medicinal Cannabis Distributors and Customers
14.3. Medicinal Cannabis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GreenWich
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbvie
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Insys Therapeutics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Valeant Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Tilray
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Corbus Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aphria
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Manitoba Harvest
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Phytokann
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Botanical Genetics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Jinzhou Qiaopai Biotech
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook